N-tert-butyl-3-[5-methyl-2-{[4-(2-pryyolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl-amino] benzenesulfonamide dihydrochloride monohydrate

N-tert-butyl-3-[5-methyl-2-{[4-(2-pryyolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl-amino] benzenesulfonamide dihydrochloride monohydrate
Trade Name
Orphan Indication Myelofibrosis
USA Market Approval USA
USA Designation Date 2009-05-18 00:00:00
Sponsor Impact Biomedicines;12526 High Bluff Drive, Suite 260;San Diego, California, 92130